Wednesday, November 25, 2009

Rheumatoid Arthritis Home>
Rheumatoid Arthritis News>
Some RA, Crohn's drugs boost cancer risk in kids: study

Font size
- A
- A
- A
Email This

Bookmark

Save

Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

Some RA, Crohn's drugs boost cancer risk in kids: study

(HealthScout) UPDATED 2009-08-04

Officials with the U.S. Food and Drug Administration (FDA) say TNF blockers--drugs commonly used to treat rheumatoid arthritis, Crohn's disease, and other inflammatory conditions--must now carry a black box warning to alert parents and doctors about an increased risk of cancer in children and teens who take them. The FDA's move comes after an analysis of data on the drugs showed a higher risk of lymphoma and other cancer associated with the use of TNF blockers such as Enbrel, Humira, and Remicade in kids. The medications already carry a FDA warning labels for other potential safety issues, including fungal infections. Read full story >

See all Rheumatoid Arthritis News

Related: Enbrel, Humira, Remicade

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.